Loading...
Chemical structure of LY3214996

GC19235

LY3214996

Also known as 6,6-dimethyl-2-[2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]-5-(2-morpholin-4-ylethyl)thieno[2,3-c]pyrrol-4-one

LY3214996 (LY3214996) is a highly selective inhibitor of ERK1 and ERK2, with IC50 of 5 nM for both enzymes in biochemical assays· LY3214996 potently inhibits cellular p-RSK1 in BRAF and RAS mutant cancer cell lines· LY3214996 shows potent antitumor activities in cancer models with MAPK pathway alterations

ChemicalCAS1951483-29-6MW453.56FormulaC22H27N7O2S
CAS number
1951483-29-6
Molecular weight
453.56
Formula
C22H27N7O2S
Solubility
DMSO : 20 mg/mL (44·10 mM)
InChIKey
JNPRPMBJODOFEC-UHFFFAOYSA-N
Catalogue number
GC19235
Brand
GLPBIO
Computed properties PubChem CID 121408882 · XLogP 1.4 · TPSA 117 Ų · H-bond donors 1
XLogP
1.4
TPSA
117 Ų
H-bond donors
1
H-bond acceptors
8
Rotatable bonds
6
Heavy atoms
32

SMILES CC1(C2=C(C=C(S2)C3=NC(=NC=C3)NC4=CC=NN4C)C(=O)N1CCN5CCOCC5)C

Computed descriptors from PubChem (CID 121408882), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.